View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
September 21, 2011

Sanofi to enter lucrative acne market

France-based pharmaceutical major Sanofi has acquired the rights to an investigational acne treatment, signalling a move into the lucrative market.

By Liam Stoker

France-based pharmaceutical major Sanofi has acquired the rights to an investigational acne treatment, signalling a move into the lucrative market.

The company’s Sanofi Pasteur unit has signed a collaboration agreement with the University of California, San Diego, US, to focus on acne prevention through an immunological approach.

Sanofi estimates that the worldwide market for acne treatments could be worth in excess of $3bn per year, with more than 50 million people suffering from acne in the US alone.

Financial terms of the agreement have not been disclosed.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology